| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $51.8M | $60.6M | $56.0M |
| YoY Revenue Growth % | -14.6% | +8.1% | — |
| Gross Profit | $22.5M | $24.8M | — |
| Gross Margin % | 43.5% | 40.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.5M | -$8.9M | -$12.4M |
| Operating Margin % | -16.4% | -14.7% | -22.1% |
| Net Income (GAAP) | -$6.4M | -$8.7M | -$12.4M |
| EBITDA (Normalized) | -$8.4M | -$8.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.1M | -$3.5M | -$3.3M |
| Capital Expenditures (CapEx) | $166.0K | $178.0K | — |
| Free Cash Flow (FCF) | -$1.3M | -$3.7M | -$3.3M |
| FCF Margin % | -2.5% | -6.1% | -5.9% |
| Return on Invested Capital (ROIC %) | -32.0% | -31.4% | — |
| Cash & Short-Term Equivalents | $7.4M | $8.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $28.3M | $31.0M | — |